Enzalutamide Enhances PSMA Expression of PSMA-Low Prostate Cancer

Prostate-specific membrane antigen (PSMA)-directed radioligand therapy (RLT) prolongs overall survival in men with metastatic castration-resistant prostate cancer (mCRPC). However, men with low PSMA expression are excluded from RLT. We explored the effect of androgen receptor blockade with enzalutam...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Int J Mol Sci
Glavni autori: Staniszewska, Magdalena, Fragoso Costa, Pedro, Eiber, Matthias, Klose, Jasmin M., Wosniack, Jasmin, Reis, Henning, Szarvas, Tibor, Hadaschik, Boris, Lückerath, Katharina, Herrmann, Ken, Fendler, Wolfgang P., Iking, Janette
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2021
Teme:
Communication
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8304389/
https://ncbi.nlm.nih.gov/pubmed/34299051
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22147431
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items